Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Summary
A multicentre, randomised, single-blind, controlled protocol to evaluate the efficacy of early administration of botulinum toxin for primary midline closure in patients with open abdomen. Early use (less than 48 hours) of botulinum toxin as a neuromuscular abdominal wall blocker in patients whose abdomen is left open, regardless of the cause, will improve postoperative outcome and prognosis, leading to significantly higher percentages of primary midline closure.
Official title: Botulinum Toxin in Open Abdomen Closure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-01
Completion Date
2026-12
Last Updated
2024-08-15
Healthy Volunteers
No
Interventions
Botulinum Toxin A
Botulinum Toxin
CONTROL
Saline Solution